Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea

NCT: NCT04121923 · COMPLETED

NCT IDNCT04121923
StatusCOMPLETED
Start Date2018-03-01
Completion2019-05-30

Brief Summary

The purpose of this study is to evaluate the sensitivity and specificity of the Belun Ring Pulse Oximetry system for screening of obstructive sleep apnea (OSA) in adults during standard polysomnography sleep study conditions. The primary outcome metric is the Apnea-Hypopnea Index (AHI). The goal, in its entirety, is to evaluate the performance of the Belun Ring Pulse Oximeter during a standard polysomnography sleep study and its ability to compare to the determined Apnea-Hypopnea Index (AHI) of the subjects. It is expected that the Belun Ring Pulse Oximeter will adequately record SpO2, pulse rate, body position and heart rate variability throughout the duration of the study.

Frequently Asked Questions

What is Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea?

Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea is a clinical trial registered under NCT04121923. Current status: COMPLETED.

What is the status of NCT04121923?

The current status of NCT04121923 (Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea) is: COMPLETED.

When did Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea start?

Validation of a Novel Device for Screening Patients With Symptoms of Obstructive Sleep Apnea started on 2018-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.